SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-20-021999
Filing Date
2020-10-29
Accepted
2020-10-29 16:27:23
Documents
18
Period of Report
2020-10-29
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K kmph20200819b_8k.htm 8-K 27488
2 EXHIBIT 99.1 ex_200709.htm EX-99.1 156738
3 EXHIBIT 99.2 ex_200710.htm EX-99.2 9419
4 a1.jpg GRAPHIC 11754
5 slide01.jpg GRAPHIC 28585
6 slide02.jpg GRAPHIC 132942
7 slide03.jpg GRAPHIC 30610
8 slide04.jpg GRAPHIC 95413
9 slide05.jpg GRAPHIC 70616
10 slide06.jpg GRAPHIC 74461
11 slide07.jpg GRAPHIC 88654
12 slide08.jpg GRAPHIC 88958
13 slide09.jpg GRAPHIC 95383
14 slide10.jpg GRAPHIC 84844
15 slide11.jpg GRAPHIC 75884
16 slide12.jpg GRAPHIC 84772
17 slide13.jpg GRAPHIC 85337
18 slide14.jpg GRAPHIC 28585
  Complete submission text file 0001437749-20-021999.txt   1671880
Mailing Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747
Business Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747 (321) 939-3416
KEMPHARM, INC (Filer) CIK: 0001434647 (see all company filings)

IRS No.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36913 | Film No.: 201273019
SIC: 2834 Pharmaceutical Preparations